Edition:
United Kingdom

Cymabay Reports Q3 Loss Per Share Of $0.34


Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - Cymabay Therapeutics Inc ::CYMABAY REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q3 LOSS PER SHARE $0.34.Q3 EARNINGS PER SHARE VIEW $-0.29 -- THOMSON REUTERS I/B/E/S.HELD $198.1 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AT SEPTEMBER 30, 2018.EXISTING CASH IS EXPECTED TO FUND CURRENT OPERATING PLAN INTO 2021. 

Company Quote

6.22
-0.21 -3.27%
19 Jul 2019